Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer
2020 ◽
Vol 26
(2)
◽
pp. 221-221
2019 ◽
Vol 25
(10)
◽
pp. 1133-1139
◽
2014 ◽
Vol 18
(3)
◽
pp. 173-188
◽
2007 ◽
Vol 176
(10)
◽
pp. 1429-1434
◽